(Press-News.org) Pharmaceutical companies have paid an estimated £156 million to NHS trusts in England between 2015 and 2022 without the public being told what the payments are for, reveals an investigation by The BMJ today.
The findings raise important questions about unrecognised conflicts of interest and have led to calls for a shake-up of current transparency rules.
The BMJ tracked all disclosed non-research payments to NHS trusts in England from 2015 to 2022 reported in Disclosure UK, a database run by the Association of the British Pharmaceutical Industry (ABPI), which requires participating companies to disclose cash payments and other benefits in kind to healthcare professionals and organisations.
In total, there were 58,302 payments worth £156,882,790 made to 217 NHS trusts, which make up a fifth of the value of all payments to healthcare organisations listed in the database, such as general practices, commissioning bodies, professional societies and medical schools.
The top 10 largest recipients accumulated £49,820,043 and included Guy’s and St Thomas’, University College London Hospitals, Manchester University, Imperial College Healthcare, University Hospitals Birmingham, University Hospitals of Leicester, Oxford University Hospitals, King’s College Hospital, Barts Health and Royal Free London NHS Trusts.
The top 10 largest payments were worth £6,237,936. Most of the payments were relatively small, with 94% of payments below £10,000.
Of the 220 trusts operating in England between 2015 and 2022 only three received no payments, including two ambulance trusts.
The BMJ approached trusts for more detail but few were able to explain the purpose behind these payments. Some trusts said they found mistakes in the data, but would not provide more detail. Guy’s and St Thomas’ NHS Foundation Trust in London said it did not “recognise these figures as accurate.”
Margaret McCartney, a general practitioner and transparency campaigner, questions whether it is “in the patient and public interest that such massive transfers of value are occurring between the pharmaceutical industry and the NHS?”
“When companies dole out over £156 million, they are not doing it out of the goodness of their heart, they are doing it because they expect some kind of return on their investment. The unanswered question, so far, is what do they want?” comments Joel Lexchin at York University, Toronto, Canada.
International experts slammed the Disclosure UK data quality and the lack of transparency of the NHS trusts.
“Legislation like the Sunshine Act in the United States that mandates disclosure by drug and device companies of transfers of value greater than US $10 to teaching hospitals is what is required,” says Joel Lexchin.
Quinn Grundy at the University of Toronto adds: "For true transparency to exist, data on pharmaceutical company payments to publicly-funded hospitals needs to be not just available, but easily accessible, accurate, complete, and provide enough detail that members of the public understand why the company made the payment and what the hospital does with the money.”
“Disclosure UK is widely regarded as a European leader in transparency”, said Amit Aggarwal, ABPI executive director of Medical Affairs and Strategic Partnerships. Since its launch, the database has evolved, he said. “However, we recognise there is always room for improvement, and we welcome constructive recommendations”, he added.
A spokesperson for the Department of Health and Social Care (DHSC) said it had been working with healthcare providers on updated guidance regarding doctors’ potential conflicts of interest and has sought views on proposed mandatory payment reporting following recommendations of the Cumberlege review.
[Ends]
END
Investigation finds “unexplained” millions in drug industry payments to the NHS
Many trusts didn’t recognise or couldn’t verify the payments. Findings raise important questions about unrecognised conflicts of interest
2024-10-23
ELSE PRESS RELEASES FROM THIS DATE:
Maternal antibodies interfere with malaria vaccine responses
2024-10-23
Maternal antibodies passed across the placenta can interfere with the response to the malaria vaccine, which would explain its lower efficacy in infants under five months of age, according to research led by the Barcelona Institute for Global Health (ISGlobal), in collaboration with seven African centers (CISM-Mozambique, IHI-Tanzania, CRUN-Burkina Faso, KHRC-Ghana, NNIMR-Ghana, CERMEL-Gabon, KEMRI-Kenya). The findings, published in Lancet Infectious Diseases, suggest that children younger than currently recommended by the WHO may benefit from the RTS,S and R21 malaria vaccines if they live in areas with low malaria transmission, ...
Teaching must be made more attractive as a profession to tackle shortages
2024-10-23
Teaching needs to be made more attractive to a wider pool of graduates to tackle shortages in the profession, according to new international research comparing 18 countries.
The worldwide comparison led by Durham University, UK, shows that the level of pay relative to other graduate professions, lack of resources and poor student behaviour all play a part in recruitment and retention issues.
Popular quick-fix strategies used across the world to attract and retain teachers, such as bursaries, scholarships and ...
Airbnb rentals linked to increased crime rates in London neighborhoods – study
2024-10-23
Latest research has revealed a “positive association” between the number of properties listed as Airbnb rentals and police-reported robberies and violent crimes in thousands of London neighbourhoods between 2015 and 2018.
In fact, the study from University of Cambridge and the University of Pennsylvania suggests that a 10% increase in active Airbnb rentals in the city would correspond to an additional 1,000 robberies per year across London.*
Urban sociologists say the rapid pace at which crime rises in conjunction with new rentals suggests that the link is related more to opportunities for crime, rather than loss ...
UK budget 'blindness' risks handing green economy future to China, report argues
2024-10-23
A new report by researchers from the University of Cambridge and the London School of Economics and Political Science (LSE) argues the UK government should invest in green infrastructure now or watch productivity lag behind China, the United States and other countries already running away with the benefits.
Is reaching net zero a growth and prosperity plan? by former Head of Economic Forecasting at the UK Treasury, Dimitri Zenghelis, says the government’s self-imposed rules on infrastructure investment must be modernised to spur the innovation needed for UK prosperity.
The ...
Marri trees a lifeline for many native bee species in biodiversity hotspot
2024-10-23
New Curtin-led research has revealed Marri trees are critical to the survival of more than 80 species of native bee in Western Australia’s South West region, which is one of the world’s most biologically rich but threatened biodiversity hotspots.
Lead author Dr Kit Prendergast, Adjunct Research Fellow from the Curtin School of Molecular and Life Sciences, said the study identified the Marri (Corymbia calophylla), which is native to the South West and was named a ‘near threatened’ species in 2019, as a crucial supplier of food for native bees and supporter of the region’s ecosystem.
“The findings that these trees support at ...
Treatments used for HER2-positive breast cancers could help patients with rare gastrointestinal cancer
2024-10-23
Barcelona, Spain: Drugs designed to target HER2-postive breast cancer could also benefit some patients with bile duct cancer, according to results of a patient trial to be presented on Thursday at the 36th EORTC-NCI-AACR [1] Symposium on Molecular Targets and Cancer Therapeutics in Barcelona, Spain. Bile duct cancer is rare, treatment options are limited, and the survival rates are low.
The trial also suggests that a wider group of breast cancer patients – those with HER2-mutated breast cancer – could be treated with these ...
Little-studied RNA might be key to regulating genetic disorders like epilepsy, autism
2024-10-23
Study focused on ‘Goldilocks Gene’ CHD2 that causes autism and epilepsy
Deletion of long non-coding RNA CHASERR produces too much CHD2 protein in the cell, leaving patients wheelchair-bound, nonverbal and with intellectual delays
Patient’s dad from study: ‘We intuitively understood this was a lot bigger than just Emma’
‘It is mind-boggling that we only know what 1% of the human genome does’
CHICAGO --- When a gene produces too much protein, it can have devastating consequences on brain development and function. ...
UB researchers show why cannabis policies should shift to a harm reduction, health promotion approach to safeguard public health
2024-10-23
BUFFALO, N.Y. — Millions of Americans use cannabis to treat a plethora of health conditions. They are rarely under a health care provider’s supervision and their access to quality information about the substances they are consuming and their potential risks is limited at best.
A paper published today in the American Journal of Public Health, the official journal of the American Public Health Association, by University at Buffalo researchers calls attention to this concerning and potentially dangerous situation, which they say is a result of a policy environment historically driven by politics, not science.
The paper explains why there needs to be a shift in cannabis ...
Live well, think well: Research shows healthy habits tied to brain health
2024-10-23
EMBARGOED FOR RELEASE UNTIL 4 P.M. ET, WEDNESDAY, OCTOBER 23, 2024
MINNEAPOLIS – In middle-aged people, having risk factors like blood pressure, blood sugar and cholesterol that are not well-controlled combined with not following certain healthy habits including exercise, diet and sleep, are linked to a higher risk of stroke, dementia or depression later in life, according to a study published in the October 23, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology. These results do not prove that not having healthy habits increases the risk of these conditions, ...
Could poor sleep in middle age speed up brain aging?
2024-10-23
EMBARGOED FOR RELEASE UNTIL 4 P.M. ET, WEDNESDAY, OCTOBER 23, 2024
MINNEAPOLIS – People in early middle age who have poor sleep quality, including having difficulty falling or staying asleep, have more signs of poor brain health in late middle age, according to a study published in the October 23, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study does not prove that poor sleep accelerates brain aging. It only shows an association between poor sleep quality and signs ...
LAST 30 PRESS RELEASES:
A graphene sandwich — deposited or transferred?
New light-powered motor fits inside a strand of hair
Oil rig study reveals vital role of tiny hoverflies
Children’s Hospital of Philadelphia researchers boost widespread use of dental varnish across pediatric network
iRECODE: A new computational method that brings clarity to single-cell analysis
New NUS-MOH study: Singapore’s healthcare sector carbon emissions 18% lower than expected, a milestone in the city-state’s net zero journey
QUT scientists create material to turn waste heat into clean power
Major new report sets out how to tackle the ‘profound and lasting impact’ of COVID-19 on cardiovascular health
Cosmic crime scene: White dwarf found devouring Pluto-like icy world
Major report tackles Covid’s cardiovascular crisis head-on
A third of licensed GPs in England not working in NHS general practice
ChatGPT “thought on the fly” when put through Ancient Greek maths puzzle
Engineers uncover why tiny particles form clusters in turbulent air
GLP-1RA drugs dramatically reduce death and cardiovascular risk in psoriasis patients
Psoriasis linked to increased risk of vision-threatening eye disease, study finds
Reprogramming obesity: New drug from Italian biotech aims to treat the underlying causes of obesity
Type 2 diabetes may accelerate development of multiple chronic diseases, particularly in the early stages, UK Biobank study suggests
Resistance training may improve nerve health, slow aging process, study shows
Common and inexpensive medicine halves the risk of recurrence in patients with colorectal cancer
SwRI-built instruments to monitor, provide advanced warning of space weather events
Breakthrough advances sodium-based battery design
New targeted radiation therapy shows near-complete response in rare sarcoma patients
Does physical frailty contribute to dementia?
Soccer headers and brain health: Study finds changes within folds of the brain
Decoding plants’ language of light
UNC Greensboro study finds ticks carrying Lyme disease moving into western NC
New implant restores blood pressure balance after spinal cord injury
New York City's medical specialist advantage may be an illusion, new NYU Tandon research shows
Could a local anesthetic that doesn’t impair motor function be within reach?
1 in 8 Italian cetacean strandings show evidence of fishery interactions, with bottlenose and striped dolphins most commonly affected, according to analysis across four decades of data and more than 5
[Press-News.org] Investigation finds “unexplained” millions in drug industry payments to the NHSMany trusts didn’t recognise or couldn’t verify the payments. Findings raise important questions about unrecognised conflicts of interest